Welcome to DU!
The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards.
Join the community:
Create a free account
Support DU (and get rid of ads!):
Become a Star Member
Latest Breaking News
Editorials & Other Articles
General Discussion
The DU Lounge
All Forums
Issue Forums
Culture Forums
Alliance Forums
Region Forums
Support Forums
Help & Search
Nevada
Related: About this forumTwo dozen companies could be fined $20 million by state for noncompliance with diabetes drug
Two dozen companies could be fined $20 million by state for noncompliance with diabetes drug transparency lawThe Nevada Department of Health and Human Services is threatening to levy roughly $20 million in fines on more than two dozen drug manufacturers that have yet to submit cost and profit reports to the state as required by a 2017 law aimed at better understanding the rising costs of treating diabetes.
In letters sent to the companies this week, the department reiterated that all manufacturers of what it determines to be drugs essential to the treatment of diabetes are required to submit annual reports to the state under Nevada law, and that companies can be assessed a fine of up to $5,000 a day for noncompliance. With 143 days since the manufacturer reports were due on April 1, each company that has yet to submit a report is facing a fine of up to $715,000.
Under the 2017 diabetes drug transparency law, the annual reports are required to include production costs, administrative expenditures, profits, financial assistance, coupons, and other information in an effort to better understand why the disease is so costly to treat. Roughly 13 percent of adults suffer from diabetes in Nevada, with direct and indirect diabetes-related medical expenses totaling $2.7 billion a year in the state.
Manufacturers are also required to provide to the state additional information for drugs determined to have experienced a significant price increase, including a list of each factor that contributed to the increase and the percentage of the total increase attributable to each factor.
Read more: https://thenevadaindependent.com/article/two-dozen-companies-could-be-fined-20-million-by-state-for-noncompliance-with-diabetes-drug-transparency-law
2 replies
= new reply since forum marked as read
Highlight:
NoneDon't highlight anything
5 newestHighlight 5 most recent replies
Two dozen companies could be fined $20 million by state for noncompliance with diabetes drug (Original Post)
TexasTowelie
Aug 2019
OP
AllaN01Bear
(23,354 posts)1. yes.fine them where it hurts.
KY_EnviroGuy
(14,606 posts)2. Pharmaceutical companies don't want their obscene profitability exposed.
Due to the prevailing attitudes of the stock market, it perfectly OK to do anything possible to increase profits and therefore show increasing margins. Thereby, stock prices go up. The pharmaceutical industry pushes this practice to the absolute limit just because they can. If this was done with groceries or gasoline, there would be riots.
But we almost never see a company take a reverse measure in that regard to benefit customers or employees. Wall Street would punish the company brutally.
And, when they claim they're doing something to benefit customers, it's always bullshit.......